Literature DB >> 31220955

Extended release formulations using silk proteins for controlled delivery of therapeutics.

Burcin Yavuz1, Laura Chambre1, David L Kaplan1.   

Abstract

INTRODUCTION: Silk is a promising biomaterial for controlled delivery of therapeutics and has a unique protein chemistry that can be tuned to form different carrier formats. The protein has been studied for sustained release depot systems for the targeted or localized delivery of drugs. AREAS COVERED: An overview of natural silk proteins for controlled delivery of therapeutics is provided, with a focus on the features of silk proteins that allow them to be useful tools for controlled delivery. Recent applications of natural silk proteins as controlled delivery systems are also summarized. EXPERT OPINION: The versatility of silk proteins makes them desirable biomaterials for a broad range of applications for controlled delivery of both small and large molecules. Further, the degradation profile leading to peptides and amino acids provides compatibility with pH-sensitive therapeutics. While silk sericin and spider silks are under study, silk fibroin extracted from silkworms (e.g. Bombyx mori) dominates pharmaceutical studies with silk. Silk fibroin can be formed into drug delivery tools for systemic or local injections, topical and transdermal applications, and implantation; depending on the target disease and therapeutic molecule. In vitro to in vivo correlations and scale-up needs are the next steps towards clinical applications.

Entities:  

Keywords:  Silk; controlled release; drug delivery; hydrogels; implants; microneedles; nanoparticles

Mesh:

Substances:

Year:  2019        PMID: 31220955      PMCID: PMC6642005          DOI: 10.1080/17425247.2019.1635116

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  114 in total

1.  The biocompatibility of silk fibroin and acellular collagen scaffolds for tissue engineering in the ear.

Authors:  Yi Shen; Sharon L Redmond; John M Papadimitriou; Bing M Teh; Sheng Yan; Yan Wang; Marcus D Atlas; Robert J Marano; Minghao Zheng; Rodney J Dilley
Journal:  Biomed Mater       Date:  2014-01-23       Impact factor: 3.715

2.  Water-based preparation of spider silk films as drug delivery matrices.

Authors:  Elisa Agostini; Gerhard Winter; Julia Engert
Journal:  J Control Release       Date:  2015-06-20       Impact factor: 9.776

3.  The use of sulfonated silk fibroin derivatives to control binding, delivery and potency of FGF-2 in tissue regeneration.

Authors:  Esther Wenk; Amanda R Murphy; David L Kaplan; Lorenz Meinel; Hans P Merkle; Lorenz Uebersax
Journal:  Biomaterials       Date:  2009-11-25       Impact factor: 12.479

4.  Sustained delivery of vincristine inside an orthotopic mouse sarcoma model decreases tumor growth.

Authors:  Jamie C Harris; Jeannine M Coburn; Andre Kajdacsy-Balla; David L Kaplan; Bill Chiu
Journal:  J Pediatr Surg       Date:  2016-09-16       Impact factor: 2.545

5.  Folate conjugated silk fibroin nanocarriers for targeted drug delivery.

Authors:  Bano Subia; Sourov Chandra; Sarmistha Talukdar; Subhas C Kundu
Journal:  Integr Biol (Camb)       Date:  2014-02       Impact factor: 2.192

6.  Silk fibroin nanoparticles prepared by electrospray as controlled release carriers of cisplatin.

Authors:  Jing Qu; Yu Liu; Yanni Yu; Jing Li; Jingwan Luo; Mingzhong Li
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2014-08-16       Impact factor: 7.328

7.  Microvascular maturity elicited in tissue treated with cytokine-loaded hyaluronan-based hydrogels.

Authors:  Luke W Hosack; Matthew A Firpo; J Anna Scott; Glenn D Prestwich; Robert A Peattie
Journal:  Biomaterials       Date:  2008-03-03       Impact factor: 12.479

8.  In vitro and in vivo evaluation of etoposide - silk wafers for neuroblastoma treatment.

Authors:  Burcin Yavuz; Jasmine Zeki; Jeannine M Coburn; Naohiko Ikegaki; Daniel Levitin; David L Kaplan; Bill Chiu
Journal:  J Control Release       Date:  2018-07-03       Impact factor: 9.776

9.  Silk Fibroin-Based Fibrous Anal Fistula Plug with Drug Delivery Function.

Authors:  Xusheng Xie; Lei Liu; Zhaozhu Zheng; Zhifen Han; Min Zhi; David L Kaplan; Gang Li; Xiaoqin Wang
Journal:  Macromol Biosci       Date:  2018-02-07       Impact factor: 4.979

Review 10.  Application of hyaluronic acid as carriers in drug delivery.

Authors:  Gangliang Huang; Hualiang Huang
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

View more
  5 in total

1.  Enhancing sustained-release local therapy: Single versus dual chemotherapy for the treatment of neuroblastoma.

Authors:  Jordan S Taylor; Burcin Yavuz; Jasmine Zeki; Lauren Wood; Naohiko Ikegaki; Jeannine Coburn; Kristin Harrington; Hiroyuki Shimada; David L Kaplan; Bill Chiu
Journal:  Surgery       Date:  2020-02-28       Impact factor: 3.982

Review 2.  Sericin based nanoformulations: a comprehensive review on molecular mechanisms of interaction with organisms to biological applications.

Authors:  Gitishree Das; Han-Seung Shin; Estefânia V Ramos Campos; Leonardo Fernandes Fraceto; Maria Del Pilar Rodriguez-Torres; Kelli Cristina Freitas Mariano; Daniele Ribeiro de Araujo; Fabián Fernández-Luqueño; Renato Grillo; Jayanta Kumar Patra
Journal:  J Nanobiotechnology       Date:  2021-01-22       Impact factor: 10.435

Review 3.  The Use of Micro- and Nanocarriers for Resveratrol Delivery into and across the Skin in Different Skin Diseases-A Literature Review.

Authors:  Beata Szulc-Musioł; Beata Sarecka-Hujar
Journal:  Pharmaceutics       Date:  2021-03-26       Impact factor: 6.321

Review 4.  Polymeric microneedle-mediated sustained release systems: Design strategies and promising applications for drug delivery.

Authors:  Li Yang; Yao Yang; Hongzhong Chen; Lin Mei; Xiaowei Zeng
Journal:  Asian J Pharm Sci       Date:  2021-07-24       Impact factor: 6.598

5.  Bioinspired biliverdin/silk fibroin hydrogel for antiglioma photothermal therapy and wound healing.

Authors:  Qing Yao; Qing-Hua Lan; Xinyu Jiang; Chu-Chu Du; Yuan-Yuan Zhai; Xiaohan Shen; He-Lin Xu; Jian Xiao; Longfa Kou; Ying-Zheng Zhao
Journal:  Theranostics       Date:  2020-09-23       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.